Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells.

W E Hinds, N Takai, B Rapoport

    The Journal of Clinical Endocrinology and Metabolism
    |June 1, 1981
    PubMed
    Summary

    This study presents a modified cultured thyroid cell cyclic adenosine monophosphate (cAMP) assay for measuring thyroid-stimulating immunoglobulins (TSI). The enhanced assay demonstrated high sensitivity and precision, detecting TSI activity in 83% of Graves' disease patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Expression of dihomo-γ-linolenic acid and FADS1/2 and ELOVL2/5 in term rabbit placentas.

    Prostaglandins, leukotrienes, and essential fatty acids·2024
    Same author

    Emerging markers of cancer cachexia and their relationship to sarcopenia.

    Journal of cancer research and clinical oncology·2023
    Same author

    To reflect human autoimmune thyroiditis, thyroid peroxidase (not thyroglobulin) antibodies should be measured in female (not sex-independent) NOD.H2<sup>h4</sup> mice.

    Clinical and experimental immunology·2018
    Same author

    High-level intrathymic thyrotrophin receptor expression in thyroiditis-prone mice protects against the spontaneous generation of pathogenic thyrotrophin receptor autoantibodies.

    Clinical and experimental immunology·2017
    Same author

    Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    Evidence that MHC I-E dampens thyroid autoantibodies and prevents spreading to a second thyroid autoantigen in I-A(k) NOD mice.

    Genes and immunity·2015

    Area of Science:

    • Endocrinology
    • Immunology
    • Cell Biology

    Background:

    • Graves' disease is an autoimmune disorder characterized by thyroid hyperstimulation.
    • Accurate measurement of thyroid-stimulating immunoglobulins (TSI) is crucial for diagnosing and managing Graves' disease.
    • Existing assays for TSI have limitations in sensitivity and convenience.

    Purpose of the Study:

    • To modify and validate a cultured thyroid cell cyclic adenosine monophosphate (cAMP) assay for measuring TSI.
    • To compare the performance of the modified assay with traditional thyroid slice and plasma membrane adenylate cyclase assays.
    • To assess the sensitivity and precision of the enhanced TSI assay.

    Main Methods:

    • Cultured human thyroid cells were used to measure cAMP response to TSH and immunoglobulin G (IgG).

    Related Experiment Videos

  • Modifications included a scaled-down microtiter well format and acetylation for enhanced cAMP detection via radioimmunoassay (RIA).
  • Assay performance was compared against thyroid slice and membrane adenylate cyclase assays using IgG from Graves' disease patients.

    • Main Results:

    • The modified cultured thyroid cell cAMP assay detected significant TSI activity in 5 of 7 (71%) untreated Graves' disease patients.
    • Traditional thyroid slice and membrane adenylate cyclase assays showed no significant TSI activity in the same samples.
    • A further optimized RIA version detected significant TSI activity in 15 of 18 (83%) untreated Graves' disease patients.

    Conclusions:

    • The modified cultured thyroid cell cAMP assay offers superior sensitivity and precision for TSI measurement compared to other methods.
    • This assay is a convenient and effective tool for detecting TSI in patients with Graves' disease.
    • The findings highlight the assay's potential for improved diagnosis and management of autoimmune thyroid disorders.